Medical Equipment - Philadelphia, PA, US
SOLUtion Medical is developing a drug delivery device for patient-injected medications that require mixing directly prior to injection. The self-injection market is growing. Worldwide healthcare is trending towards more at-home treatments and pharma companies are seeking ways to deliver high-volume drugs for self-treatment in a timely manner. The self-injected drug delivery market is approximately $38B and has been growing at a CAGR of 19%. A large percentage of these drugs currently require lyophilization, and the FDA predicts 50% of all injectable drugs will require reconstitution in the near future.SOLUtion's beachhead market is a rescue autoinjector for individuals at risk of an adrenal crisis, a situation similar to anaphylaxis where a patient's body experiences physical and mental debilitation requiring immediate injection of hydrocortisone sodium succinate (HSS). The current and only adrenal crisis rescue injection on the market comes in the form of the Act-o-Vial, a system requiring 14 user steps, including cumbersome drug mixing, prior to injection.
Gmail
WordPress.org
Google Font API
Mobile Friendly
GoDaddy Hosting